Get all your news in one place.

100's of premium titles.
One app.

Get all your news in one place.

100's of premium titles. One news app.

UNCOVERED: Kodiak sciences - Caught on Camera

3 Small-Cap Biotechs With Binary Catalysts on the Calendar

Kodiak Sciences, Capricor Therapeutics and Invivyd each face pivotal clinical trial or FDA decisions before the end of 2026 that could significantly move their stock prices.

Ameresco, Lithium Americas, Kodiak Sciences And Other Big Stocks Moving Higher On Thursday

Ameresco, Lithium Americas, Kodiak Sciences And Other Big Stocks Moving Higher On Thursday

U.S. stocks were lower, with the Nasdaq Composite falling more than 100 points on Thursday.

Jim Cramer: Kodiak Sciences Is A 'Pure Spec' Stock, Recommends Buying This Utilities Stock

Jim Cramer: Kodiak Sciences Is A 'Pure Spec' Stock, Recommends Buying This Utilities Stock

On the latest edition of CNBC's “Mad Money Lightning Round,” Jim Cramer called Kodiak Sciences Inc. (NASDAQ:KOD) is a “pure spec” stock.

From analysis to the latest developments in health,
read the most diverse news in one place.

inkl

United Airlines And 3 Other Stocks Insiders Are Buying

Although US stocks closed slightly higher on Monday, there were a few notable insider trades.

What 5 Analyst Ratings Have To Say About Kodiak Sciences

Within the last quarter, Kodiak Sciences (NASDAQ:KOD) has observed the following analyst ratings:

Analyst Ratings for Kodiak Sciences

Within the last quarter, Kodiak Sciences (NASDAQ:KOD) has observed the following analyst ratings:

Recap: Kodiak Sciences Q4 Earnings

Kodiak Sciences (NASDAQ:KOD) reported its Q4 earnings results on Tuesday, March 1, 2022 at 04:10 PM. Here's what investors need to know about the announcement.

inkl

Read news from The Economist, FT, and more,
with one subscription

Expert Ratings For Kodiak Sciences

Expert Ratings For Kodiak Sciences

Analysts have provided the following ratings for Kodiak Sciences (NASDAQ:KOD) within the last quarter:

Why Kodiak Sciences Shares Are Plunging Today

Why Kodiak Sciences Shares Are Plunging Today

Kodiak Sciences Inc (NASDAQ: KOD) has announced topline results from its Phase 2b/3 trial evaluating KSI-301 in treatment-naïve subjects with neovascular (wet) age-related macular degeneration.

What 4 Analyst Ratings Have To Say About Kodiak Sciences

What 4 Analyst Ratings Have To Say About Kodiak Sciences

Within the last quarter, Kodiak Sciences (NASDAQ:KOD) has observed the following analyst ratings:

3 Stocks Insiders Are Buying: Kodiak Sciences, EverQuote And More

3 Stocks Insiders Are Buying: Kodiak Sciences, EverQuote And More

Crude oil prices traded higher on Wednesday after gaining close to 3% in the prior session, as the API reported that US crude stockpiles dropped by 875,000 barrels last week.

1

People

From analysis to the latest developments in health,
read the most diverse news in one place.

inkl

Organisations

United Airlines

Texas Pacific Land

Kodiak Sciences

inkl

Read news from The Economist, FT, and more,
with one subscription

Topics

Places

418,126 stories

Fourteen days free

Download the app

One app. One membership.
100+ trusted global sources.

Download on the AppStore

Get it on Google Play